Literature DB >> 26526942

Metabolic Reprogramming in Brain Cancer: A Coordinated Effort.

Sriram Venneti1, Paul S Mischel2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26526942      PMCID： PMC5096791          DOI： 10.1111/bpa.12308

Source DB:  PubMed          Journal:  Brain Pathol        ISSN： 1015-6305            Impact factor:   6.508


× No keyword cloud information.
  10 in total

Review 1.  Glutamine and cancer: cell biology, physiology, and clinical opportunities.

Authors:  Christopher T Hensley; Ajla T Wasti; Ralph J DeBerardinis
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

Review 2.  Metabolic reprogramming: a cancer hallmark even warburg did not anticipate.

Authors:  Patrick S Ward; Craig B Thompson
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

Review 3.  Cellular fatty acid metabolism and cancer.

Authors:  Erin Currie; Almut Schulze; Rudolf Zechner; Tobias C Walther; Robert V Farese
Journal:  Cell Metab       Date:  2013-06-20       Impact factor: 27.287

4.  EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy.

Authors:  Deliang Guo; Robert M Prins; Julie Dang; Daisuke Kuga; Akio Iwanami; Horacio Soto; Kelly Y Lin; Tiffany T Huang; David Akhavan; M Benjamin Hock; Shaojun Zhu; Ava A Kofman; Steve J Bensinger; William H Yong; Harry V Vinters; Steve Horvath; Andrew D Watson; John G Kuhn; H Ian Robins; Minesh P Mehta; Patrick Y Wen; Lisa M DeAngelis; Michael D Prados; Ingo K Mellinghoff; Timothy F Cloughesy; Paul S Mischel
Journal:  Sci Signal       Date:  2009-12-15       Impact factor: 8.192

Review 5.  The Role of Pyruvate Kinase M2 in Cancer Metabolism.

Authors:  Vivian M Liu; Matthew G Vander Heiden
Journal:  Brain Pathol       Date:  2015-11       Impact factor: 6.508

Review 6.  mTORC2 and Metabolic Reprogramming in GBM: at the Interface of Genetics and Environment.

Authors:  Kenta Masui; Webster K Cavenee; Paul S Mischel
Journal:  Brain Pathol       Date:  2015-11       Impact factor: 6.508

Review 7.  Magnetic Resonance (MR) Metabolic Imaging in Glioma.

Authors:  Myriam M Chaumeil; Janine M Lupo; Sabrina M Ronen
Journal:  Brain Pathol       Date:  2015-11       Impact factor: 6.508

Review 8.  2-Hydoxyglutarate: D/Riving Pathology in gLiomaS.

Authors:  Daniel R Wahl; Sriram Venneti
Journal:  Brain Pathol       Date:  2015-11       Impact factor: 6.508

Review 9.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

10.  SREBP maintains lipid biosynthesis and viability of cancer cells under lipid- and oxygen-deprived conditions and defines a gene signature associated with poor survival in glioblastoma multiforme.

Authors:  C A Lewis; C Brault; B Peck; K Bensaad; B Griffiths; R Mitter; P Chakravarty; P East; B Dankworth; D Alibhai; A L Harris; A Schulze
Journal:  Oncogene       Date:  2015-01-26       Impact factor: 9.867
  10 in total
  2 in total

1.  Toxic effects of phytol and retinol on human glioblastoma cells are associated with modulation of cholesterol and fatty acid biosynthetic pathways.

Authors:  Gustavo Facchini; Raffaela Silvestre Ignarro; Erika Rodrigues-Silva; André Schwambach Vieira; Iscia Lopes-Cendes; Roger Frigério Castilho; Fabio Rogerio
Journal:  J Neurooncol       Date:  2017-11-20       Impact factor: 4.130

Review 2.  Biomarkers Regulated by Lipid-Soluble Vitamins in Glioblastoma.

Authors:  Dina El-Rabie Osman; Brandon Wee Siang Phon; Muhamad Noor Alfarizal Kamarudin; Stephen Navendran Ponnampalam; Ammu Kutty Radhakrishnan; Saatheeyavaane Bhuvanendran
Journal:  Nutrients       Date:  2022-07-13       Impact factor: 6.706
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.